Literature DB >> 111246

Immunosuppression by a mouse tumor resembles antigenic competition.

C G Cocito, B Michot, J Radovich, D W Talmage.   

Abstract

The intraperitoneal injection of gamma-radiated, UV-radiated, or unradiated P-815 tumor cells into syngeneic or allogeneic mice suppressed the immune response to a subsequent intraperitoneal injection of sheep erythrocytes in a manner similar to the suppression caused by the injection of manner similar to the suppression caused by the injection of horse erythrocytes and termed antigenic competition. In both cases, the greatest suppression occurred when the sheep erythrocytes were injected at the same site (intraperitoneal) as the tumor or antigen several days after the tumor or antigen and in a dose of 10(8) erythrocytes or less.

Entities:  

Mesh:

Year:  1979        PMID: 111246      PMCID: PMC383716          DOI: 10.1073/pnas.76.6.2895

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  Antigenic competition: cellular or humoral.

Authors:  J Radovich; D W Talmage
Journal:  Science       Date:  1967-10-27       Impact factor: 47.728

2.  Immunosuppressive and immunostimulatory factors produced by malignant cells in vitro.

Authors:  A Wong; R Mankovitz; J C Kennedy
Journal:  Int J Cancer       Date:  1974-04-15       Impact factor: 7.396

Review 3.  Plaque forming cells: methodology and theory.

Authors:  N K Jerne; C Henry; A A Nordin; H Fuji; A M Koros; I Lefkovits
Journal:  Transplant Rev       Date:  1974

4.  Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma.

Authors:  W F Sample; H R Gertner; P B Chretien
Journal:  J Natl Cancer Inst       Date:  1971-06       Impact factor: 13.506

5.  Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s).

Authors:  D W Talmage; J A Woolnough; H Hemmingsen; L Lopez; K J Lafferty
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

Review 6.  Immunodeficiency and cancer.

Authors:  J H Kersey; B D Spector; R A Good
Journal:  Adv Cancer Res       Date:  1973       Impact factor: 6.242

7.  Immunosuppression by spleen cells from Moloney leukemia. Comparison of the suppressive effect on antibody response and on mitogen-induced response.

Authors:  J Cerny; R A Stiller
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

8.  Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.

Authors:  W H Brooks; M G Netsky; D E Normansell; D A Horwitz
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

9.  Antibody-producing capacity in human cancer.

Authors:  A K Lee; M Rowley; I R Mackay
Journal:  Br J Cancer       Date:  1970-09       Impact factor: 7.640

10.  Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor.

Authors:  E J Field; E A Caspary
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.